NCT05905250

Brief Summary

We aim to refine and pilot test an 8-week phone- and app-based intervention to promote hope, and thereby mitigate life disruption caused by cancer diagnosis and treatment, among young adults (YAs); our proposal involves (Aim 1) formative research among YA survivors and healthcare providers; and (Aim 2) an randomized controlled trial (RCT) of the intervention vs. attention control among 150 YA cancer survivors. The proposed research is innovative in its use of: 1) a novel intervention target - hope - as a mechanism for addressing goal-disruption and quality of life (QOL) among YA survivors; and 2) novel mHealth components and population-based recruitment strategy (via social media) that are particularly relevant to YA survivors and those with potentially limited access to healthcare. This proposal has potential high impact due to the number of YA cancer survivors for whom the intervention may be relevant, the intervention's potential utility in enhancing hope and QOL among YAs, and its reach/scalability.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
155

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 26, 2023

Completed
20 days until next milestone

First Posted

Study publicly available on registry

June 15, 2023

Completed
9 months until next milestone

Study Start

First participant enrolled

March 15, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2025

Completed
10 months until next milestone

Results Posted

Study results publicly available

December 24, 2025

Completed
Last Updated

January 16, 2026

Status Verified

December 1, 2025

Enrollment Period

12 months

First QC Date

May 26, 2023

Results QC Date

October 31, 2025

Last Update Submit

December 26, 2025

Conditions

Outcome Measures

Primary Outcomes (6)

  • Retention

    Number of Participants with Retention at End of Treatment

    2 months (end-of-treatment; EOT)

  • Retention

    Number of Participants with Retention at End of Study

    4 months (follow-up; FU)

  • Adherence

    Adherence to intervention (number of sessions completed out of 8)

    2 months (end-of-treatment; EOT)

  • Acceptability

    \>75% participants reporting high satisfaction (3 or 4 on scale of 0=not at all to 4=very)

    2 months (end-of-treatment; EOT)

  • Acceptability

    \>75% report yes to "would you recommend this program to your friends who are cancer survivors?"

    2 months (end-of-treatment; EOT)

  • Hope

    Hope, per Snyder's Adult Hope Scale - a 12-item measure, each scored on a 1-8 scale; 8 items assess hope-related factors (4 are distractor/filler items), for a total score range of 8-64. Higher scores indicate higher hope (better outcome).

    4 months (follow-up; FU)

Secondary Outcomes (7)

  • Hope

    2 months (end-of-treatment; EOT)

  • Quality of Life - Patient-Reported Outcome Measurement Information System (PROMIS) Global Health Scale

    2 months (end-of-treatment; EOT)

  • Quality of Life - Patient-Reported Outcome Measurement Information System (PROMIS) Global Health Scale

    4 months (follow-up; FU)

  • Functional Assessment of Cancer Therapy - General (FACT-G)

    2 months (end-of-treatment; EOT)

  • Functional Assessment of Cancer Therapy - General (FACT-G)

    4 months (follow-up; FU)

  • +2 more secondary outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

The intervention utilizes an empirically supported protocol, further refined with evidence-based strategies targeting the needs of young adult (YA) survivors. Its long-term goal is to promote hopeful thinking, and ultimately enhance other long-term markers of quality of life (QOL) (including mental health and health behaviors). The intervention follows 8 weekly curricula, reinforced through psychoeducation and skill-building, homework/practical application, and self-monitoring. Its 8-week design was informed by cognitive behavioral therapy and positive psychology intervention literature.

Behavioral: an empirically supported protocol, further refined with evidence-based strategies

Attention Control

ACTIVE COMPARATOR

Health education regarding maintaining a healthy weight, physical activity, and nutrition, based on American Cancer Society and NCI guidelines/recommendations.

Behavioral: Health education

Interventions

The intervention utilizes an empirically supported protocol, further refined with evidence-based strategies targeting the needs of young adult (YA) survivors. Its long-term goal is to promote hopeful thinking, and ultimately enhance other long-term markers of quality of life (QOL) (including mental health and health behaviors). The intervention follows 8 weekly curricula, reinforced through psychoeducation and skill-building, homework/practical application, and self-monitoring. Its 8-week design was informed by cognitive behavioral therapy and positive psychology intervention literature.

Intervention

Health education regarding maintaining a healthy weight, physical activity, and nutrition, based on American Cancer Society and NCI guidelines/recommendations.

Attention Control

Eligibility Criteria

Age18 Years - 39 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Diagnosis of stage I-IV cancer from age 18-39
  • Completion of curative treatment (surgery, chemotherapy and/or radiation) within three years of study enrollment
  • No significant psychological disabilities
  • Able to complete forms and understand instructions in English
  • Smartphone access
  • Aim 2: Able to commit to 8-week remotely delivered study

You may not qualify if:

  • Completion of curative treatment (surgery, chemotherapy and/or radiation) over three years ago or currently in treatment
  • Significant psychological disabilities

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

George Washington University

Washington D.C., District of Columbia, 20052, United States

Location

Related Publications (3)

  • Berg CJ, McCready DM, Hinds PS, Lyon ME, Dennis K, Howlader A, Bhanot P, Shajan S, Chalasani P, Chitalia A, Arem H. Outcomes of a Randomized Controlled Trial Testing the Feasibility, Acceptability and Preliminary Efficacy of a Digital, Coach-Assisted Intervention to Enhance Hope and Quality of Life Among Young Adult Cancer Survivors. Psychooncology. 2025 Nov;34(11):e70315. doi: 10.1002/pon.70315.

  • Berg CJ, Schubel LC, McCready DM, Shajan S, Bhanot P, Dopke C, Howlader A, Hinds PS, Levine J, Lyon ME, Chalasani P, Arem H. Profiles of quality of life among US young adult cancer survivors and their associations with potential psychosocial intervention targets of hope and psychological flexibility. Qual Life Res. 2025 Sep;34(9):2677-2688. doi: 10.1007/s11136-025-04010-0. Epub 2025 Jun 28.

  • McCready DM, Arem H, Duarte DA, Dennis K, Ball N, Cafferty LA, Hinds PS, Howlader A, Berg CJ. A digital, coach-assisted intervention to address the psychosocial needs of young adult cancer survivors: Randomized controlled trial protocol and intervention adaptation process. Contemp Clin Trials. 2024 Jun;141:107545. doi: 10.1016/j.cct.2024.107545. Epub 2024 Apr 23.

MeSH Terms

Conditions

NeoplasmsPsychological Well-Being

Condition Hierarchy (Ancestors)

Personal SatisfactionBehavior

Results Point of Contact

Title
Carla Berg
Organization
The George Washington University

Study Officials

  • Carla J Berg, PhD

    George Washington University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The investigative team will be masked except in the event interventionists or data collectors require input from the team that requires disclosure of identifying information. Participants will be randomized to the intervention or attention control.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Individual randomized control trial with 1:1 randomization
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Prevention and Community Health

Study Record Dates

First Submitted

May 26, 2023

First Posted

June 15, 2023

Study Start

March 15, 2024

Primary Completion

February 28, 2025

Study Completion

February 28, 2025

Last Updated

January 16, 2026

Results First Posted

December 24, 2025

Record last verified: 2025-12

Locations